Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship with the Severity of Acute Coronary Syndromes
Overview
Authors
Affiliations
Background: There is accumulating data that acute coronary syndromes relate to recent onset activation of inflammation affecting atherosclerotic plaques. Increased blood levels of oxidized low density lipoprotein (ox-LDL) could play a role in these circumstances.
Methods And Results: Ox-LDL levels were measured in 135 patients with acute myocardial infarction (AMI; n=45), unstable angina pectoris (UAP; n=45), and stable angina pectoris (SAP; n=45) and in 46 control subjects using a sandwich ELISA method. In addition, 33 atherectomy specimens obtained from a different cohort of patients with SAP (n=10) and UAP (n=23) were studied immunohistochemically for ox-LDL. In AMI patients, ox-LDL levels were significantly higher than in patients with UAP (P<0.0005) or SAP (P<0.0001) or in controls (P<0.0001) (AMI, 1.95+/-1.42 ng/5 microgram LDL protein; UAP, 1.19+/-0.74 ng/5 microgram LDL protein; SAP, 0.89+/-0.48 ng/5 microgram LDL protein; control, 0.58+/-0.23 ng/5 microgram LDL protein). Serum levels of total, HDL, and LDL cholesterol did not differ among these patient groups. In the atherectomy specimens, the surface area containing ox-LDL-positive macrophages was significantly higher in patients with UAP than in those with SAP (P<0.0001).
Conclusions: This study demonstrates that ox-LDL levels show a significant positive correlation with the severity of acute coronary syndromes and that the more severe lesions also contain a significantly higher percentage of ox-LDL-positive macrophages. These observations suggest that increased levels of ox-LDL relate to plaque instability in human coronary atherosclerotic lesions.
Matsuo K, Inoue I, Matsuda T, Arai T, Nakano S Heart Vessels. 2024; 40(1):26-35.
PMID: 39017677 DOI: 10.1007/s00380-024-02440-3.
Munno M, Mallia A, Greco A, Modafferi G, Banfi C, Eligini S Antioxidants (Basel). 2024; 13(5).
PMID: 38790688 PMC: 11118168. DOI: 10.3390/antiox13050583.
Do patients benefit from omega-3 fatty acids?.
Sherratt S, Mason R, Libby P, Steg P, Bhatt D Cardiovasc Res. 2024; 119(18):2884-2901.
PMID: 38252923 PMC: 10874279. DOI: 10.1093/cvr/cvad188.
Field-Flow Fractionation in Molecular Biology and Biotechnology.
Giordani S, Marassi V, Placci A, Zattoni A, Roda B, Reschiglian P Molecules. 2023; 28(17).
PMID: 37687030 PMC: 10488451. DOI: 10.3390/molecules28176201.
Dragan P, Ivan S, Goran D, Maja N, Nevena L, Marijana A Life (Basel). 2023; 13(7).
PMID: 37511912 PMC: 10381699. DOI: 10.3390/life13071537.